CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has completed a $4.8 million Series Seed round of financing. Dynamk Capital and Cota Capital co-led the investment round with participation from Embark Ventures, Elm Ventures and McEwan Lane Family Trust. Dr. Gustavo Mahler, Venture Partner, Dynamk … [Read more...] about CellFE, an innovative startup developing a microfluidics based device to deliver gene-editing molecules, secures $4.8M seed round funding